Back to search

Switzerland· 55603001

Ospolot 50 mg, Filmtabletten

A sultiame product, registered in Switzerland by Desitin Pharma GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 12 of our 19 countries.

Cat B (Swissmedic)ATC N03AX03

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedOspolot 50 mg, FilmtablettenATCN03AX03REGISTER NO.55603001PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Sultiame is registered in 12 of 19 countries.

Countries holding a registration under ATC N03AX03 (sultiame), each read from that country’s own register.

  • This record: Switzerland
  • 6 of them publish a price we can compare per daily dose

Sultiame · ATC N03AX03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sultiame costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • Switzerland: $4.91 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Sultiame · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.91
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
Desitin Pharma GmbH
Country
Switzerland (CH)
ATC code
N03AX03
ATC class
Sultiame
Defined daily dose
0.4 g, O
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

12 interactions on record for sultiame.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sultiame · interactions on record

12 records

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d609c698-de0c-44a6-9cc2-7bd1508fd7cb
GET /v1/drugs/d609c698-de0c-44a6-9cc2-7bd1508fd7cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about sultiame.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.